The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review


Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Neuroblastoma


Psychiatry related information on Neuroblastoma


High impact information on Neuroblastoma


Chemical compound and disease context of Neuroblastoma


Biological context of Neuroblastoma


Anatomical context of Neuroblastoma


Gene context of Neuroblastoma


Analytical, diagnostic and therapeutic context of Neuroblastoma


  1. Endorphin from pituitary inhibits cyclic AMP formation in homogenates of neuroblastoma X glioma hybrid cells. Goldstein, A., Cox, B.M., Klee, W.A., Nirenberg, M. Nature (1977) [Pubmed]
  2. Differential expression of myc family genes during murine development. Zimmerman, K.A., Yancopoulos, G.D., Collum, R.G., Smith, R.K., Kohl, N.E., Denis, K.A., Nau, M.M., Witte, O.N., Toran-Allerand, D., Gee, C.E. Nature (1986) [Pubmed]
  3. Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Lee, W.H., Bookstein, R., Hong, F., Young, L.J., Shew, J.Y., Lee, E.Y. Science (1987) [Pubmed]
  4. Letter: Familial neuroblastoma and ganglioneuroma. Bond, J.V. JAMA (1976) [Pubmed]
  5. Human neuroblastoma cells express alpha and beta platelet-derived growth factor receptors coupling with neurotrophic and chemotactic signaling. Matsui, T., Sano, K., Tsukamoto, T., Ito, M., Takaishi, T., Nakata, H., Nakamura, H., Chihara, K. J. Clin. Invest. (1993) [Pubmed]
  6. A cellular model that recapitulates major pathogenic steps of Huntington's disease. Lunkes, A., Mandel, J.L. Hum. Mol. Genet. (1998) [Pubmed]
  7. A dinucleotide deletion in amyloid precursor protein (APP) mRNA associated with sporadic Alzheimer's disease results in efficient secretion of truncated APP isoforms from neuroblastoma cell cultures. Hersberger, M., Santiago-Garcia, J., Patarroyo-White, S., Yan, J., Xu, X. J. Neurochem. (2001) [Pubmed]
  8. Morphine dependence in human neuroblastoma SH-SY5Y cells is associated with adaptive changes in both the quantity and functional interaction of PGE1 receptors and stimulatory G proteins. Ammer, H., Schulz, R. Brain Res. (1996) [Pubmed]
  9. Nefopam blocks voltage-sensitive sodium channels and modulates glutamatergic transmission in rodents. Verleye, M., André, N., Heulard, I., Gillardin, J.M. Brain Res. (2004) [Pubmed]
  10. AP-1 and NF-kappaB stimulated by carbachol in human neuroblastoma SH-SY5Y cells are differentially sensitive to inhibition by lithium. Jope, R.S., Song, L. Brain Res. Mol. Brain Res. (1997) [Pubmed]
  11. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. Vernino, S., Low, P.A., Fealey, R.D., Stewart, J.D., Farrugia, G., Lennon, V.A. N. Engl. J. Med. (2000) [Pubmed]
  12. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. Matthay, K.K., Villablanca, J.G., Seeger, R.C., Stram, D.O., Harris, R.E., Ramsay, N.K., Swift, P., Shimada, H., Black, C.T., Brodeur, G.M., Gerbing, R.B., Reynolds, C.P. N. Engl. J. Med. (1999) [Pubmed]
  13. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Zhou, H., Kuang, J., Zhong, L., Kuo, W.L., Gray, J.W., Sahin, A., Brinkley, B.R., Sen, S. Nat. Genet. (1998) [Pubmed]
  14. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Kaghad, M., Bonnet, H., Yang, A., Creancier, L., Biscan, J.C., Valent, A., Minty, A., Chalon, P., Lelias, J.M., Dumont, X., Ferrara, P., McKeon, F., Caput, D. Cell (1997) [Pubmed]
  15. Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma. Norris, M.D., Bordow, S.B., Marshall, G.M., Haber, P.S., Cohn, S.L., Haber, M. N. Engl. J. Med. (1996) [Pubmed]
  16. Structure and activation of the human N-ras gene. Taparowsky, E., Shimizu, K., Goldfarb, M., Wigler, M. Cell (1983) [Pubmed]
  17. Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma. Thiele, C.J., Reynolds, C.P., Israel, M.A. Nature (1985) [Pubmed]
  18. Chronic ethanol causes heterologous desensitization of receptors by reducing alpha s messenger RNA. Mochly-Rosen, D., Chang, F.H., Cheever, L., Kim, M., Diamond, I., Gordon, A.S. Nature (1988) [Pubmed]
  19. Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN. Teitz, T., Wei, T., Valentine, M.B., Vanin, E.F., Grenet, J., Valentine, V.A., Behm, F.G., Look, A.T., Lahti, J.M., Kidd, V.J. Nat. Med. (2000) [Pubmed]
  20. Antipsychotics block muscarinic acetylcholine receptor-mediated cyclic GMP formation in cultured mouse neuroblastoma cells. Richelson, E. Nature (1977) [Pubmed]
  21. Thrombospondin-1 peptide ABT-510 combined with valproic acid is an effective antiangiogenesis strategy in neuroblastoma. Yang, Q., Tian, Y., Liu, S., Zeine, R., Chlenski, A., Salwen, H.R., Henkin, J., Cohn, S.L. Cancer Res. (2007) [Pubmed]
  22. Tumor regression and curability of preclinical neuroblastoma models by PEGylated SN38 (EZN-2208), a novel topoisomerase I inhibitor. Pastorino, F., Loi, M., Sapra, P., Becherini, P., Cilli, M., Emionite, L., Ribatti, D., Greenberger, L.M., Horak, I.D., Ponzoni, M. Clin. Cancer Res. (2010) [Pubmed]
  23. Polo-Like Kinase 1 is a Therapeutic Target in High-Risk Neuroblastoma. Ackermann, S., Goeser, F., Schulte, J.H., Schramm, A., Ehemann, V., Hero, B., Eggert, A., Berthold, F., Fischer, M. Clin. Cancer Res. (2011) [Pubmed]
  24. PBX1 is a favorable prognostic biomarker as it modulates 13-cis retinoic acid-mediated differentiation in neuroblastoma. Shah, N., Wang, J., Selich-Anderson, J., Graham, G., Siddiqui, H., Li, X., Khan, J., Toretsky, J. Clin. Cancer Res. (2014) [Pubmed]
  25. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. Seeger, R.C., Brodeur, G.M., Sather, H., Dalton, A., Siegel, S.E., Wong, K.Y., Hammond, D. N. Engl. J. Med. (1985) [Pubmed]
  26. Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N-myc amplification. Caron, H., van Sluis, P., van Hoeve, M., de Kraker, J., Bras, J., Slater, R., Mannens, M., Voûte, P.A., Westerveld, A., Versteeg, R. Nat. Genet. (1993) [Pubmed]
  27. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. Nakagawara, A., Arima-Nakagawara, M., Scavarda, N.J., Azar, C.G., Cantor, A.B., Brodeur, G.M. N. Engl. J. Med. (1993) [Pubmed]
  28. Preferential amplification of the paternal allele of the N-myc gene in human neuroblastomas. Cheng, J.M., Hiemstra, J.L., Schneider, S.S., Naumova, A., Cheung, N.K., Cohn, S.L., Diller, L., Sapienza, C., Brodeur, G.M. Nat. Genet. (1993) [Pubmed]
  29. N-myc amplification causes down-modulation of MHC class I antigen expression in neuroblastoma. Bernards, R., Dessain, S.K., Weinberg, R.A. Cell (1986) [Pubmed]
  30. Radioimmunoassay for tubulin: a quantitative comparison of the tubulin content of different established tissue culture cells and tissues. Hiller, G., Weber, K. Cell (1978) [Pubmed]
  31. Induction of formation of presynaptic terminals in neuroblastoma cells by synapsin IIb. Han, H.Q., Nichols, R.A., Rubin, M.R., Bähler, M., Greengard, P. Nature (1991) [Pubmed]
  32. Fetal hydantoin syndrome, neuroblastoma, and hemorrhagic disease in a neonate. Allen, R.W., Ogden, B., Bentley, F.L., Jung, A.L. JAMA (1980) [Pubmed]
  33. Inhibition of proliferation of normal and transformed neural cells by blood group-related oligosaccharides. Santos-Benito, F.F., Fernández-Mayoralas, A., Martín-Lomas, M., Nieto-Sampedro, M. J. Exp. Med. (1992) [Pubmed]
  34. Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease. Genis, P., Jett, M., Bernton, E.W., Boyle, T., Gelbard, H.A., Dzenko, K., Keane, R.W., Resnick, L., Mizrachi, Y., Volsky, D.J. J. Exp. Med. (1992) [Pubmed]
  35. Natural killer T cells infiltrate neuroblastomas expressing the chemokine CCL2. Metelitsa, L.S., Wu, H.W., Wang, H., Yang, Y., Warsi, Z., Asgharzadeh, S., Groshen, S., Wilson, S.B., Seeger, R.C. J. Exp. Med. (2004) [Pubmed]
  36. Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity. Klement, G., Baruchel, S., Rak, J., Man, S., Clark, K., Hicklin, D.J., Bohlen, P., Kerbel, R.S. J. Clin. Invest. (2000) [Pubmed]
  37. Induction of TrkB by retinoic acid mediates biologic responsiveness to BDNF and differentiation of human neuroblastoma cells. Eukaryotic Signal Transduction Group. Kaplan, D.R., Matsumoto, K., Lucarelli, E., Thiele, C.J. Neuron (1993) [Pubmed]
  38. De novo identification of MIZ-1 (ZBTB17) encoding a MYC-interacting zinc-finger protein as a new favorable neuroblastoma gene. Ikegaki, N., Gotoh, T., Kung, B., Riceberg, J.S., Kim, D.Y., Zhao, H., Rappaport, E.F., Hicks, S.L., Seeger, R.C., Tang, X.X. Clin. Cancer Res. (2007) [Pubmed]
  39. Methylation of CASP8, DCR2, and HIN-1 in neuroblastoma is associated with poor outcome. Yang, Q., Kiernan, C.M., Tian, Y., Salwen, H.R., Chlenski, A., Brumback, B.A., London, W.B., Cohn, S.L. Clin. Cancer Res. (2007) [Pubmed]
  40. Human neuroblastoma cells trigger an immunosuppressive program in monocytes by stimulating soluble HLA-G release. Morandi, F., Levreri, I., Bocca, P., Galleni, B., Raffaghello, L., Ferrone, S., Prigione, I., Pistoia, V. Cancer Res. (2007) [Pubmed]
  41. Histone deacetylase 8 in neuroblastoma tumorigenesis. Oehme, I., Deubzer, H.E., Wegener, D., Pickert, D., Linke, J.P., Hero, B., Kopp-Schneider, A., Westermann, F., Ulrich, S.M., von Deimling, A., Fischer, M., Witt, O. Clin. Cancer Res. (2009) [Pubmed]
  42. Neuroblastoma progression correlates with downregulation of the lymphangiogenesis inhibitor sVEGFR-2. Becker, J., Pavlakovic, H., Ludewig, F., Wilting, F., Weich, H.A., Albuquerque, R., Ambati, J., Wilting, J. Clin. Cancer Res. (2010) [Pubmed]
  43. Promising therapeutic targets in neuroblastoma. Matthay, K.K., George, R.E., Yu, A.L. Clin. Cancer Res. (2012) [Pubmed]
  44. A rationale for the treatment of metastatic neuroblastoma. Helson, L., Helson, C., Peterson, R.F., Das, S.K. J. Natl. Cancer Inst. (1976) [Pubmed]
  45. Neurite extension and malignancy of neuroblastoma cells after treatment with prostaglandin E1 and papaverine. Lazo, J.S., Ruddon, R.W. J. Natl. Cancer Inst. (1977) [Pubmed]
  46. Hsp27 expression in neuroblastoma: correlation with disease stage. Ungar, D.R., Hailat, N., Strahler, J.R., Kuick, R.D., Brodeur, G.M., Seeger, R.C., Reynolds, C.P., Hanash, S.M. J. Natl. Cancer Inst. (1994) [Pubmed]
  47. A novel chromosome abnormality in human neuroblastoma and antifolate-resistant Chinese hamster cell lives in culture. Biedler, J.L., Spengler, B.A. J. Natl. Cancer Inst. (1976) [Pubmed]
  48. Raised neuron-specific enolase in serum of children with metastatic neuroblastoma. A report from the Children's Cancer Study Group. Zeltzer, P.M., Marangos, P.J., Parma, A.M., Sather, H., Dalton, A., Hammond, D., Siegel, S.E., Seeger, R.C. Lancet (1983) [Pubmed]
WikiGenes - Universities